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The Journal of Thoracic and Cardiovabjective: The present study examined temporal and spatial patterns of extracellular
atrix and smooth muscle cell changes in the ascending aorta with bicuspid and
ricuspid aortic valve stenosis.
ethods: Wall specimens were retrieved from both the greater and the lesser
urvature (“convexity” and “concavity”) of 14 nonaneurysmal and 12 aneurysmal
ortas (aortic ratios 1.2 and 1.5, respectively) and from 3 heart donors (normal).
mmunochemistry was performed for detection of apoptotic (terminal deoxynucleo-
idyl transferase-mediated dUTP nick end labelling [TUNEL]-positive) and prolif-
rating (Ki-67-positive) smooth muscle cells and for semiquantification of matrix
roteins (collagens, fibronectin, tenascin, laminin). Co-immunoprecipitation as-
essed the extent of Bcl-2-modifying factor binding to Bcl-2, indicating a matrix-
erived cytoskeleton-mediated proapoptotic signaling. Polymerase chain reaction
llowed for quantification of messenger RNA expression for Bcl-2.
esults: In both bicuspid and tricuspid aneurysms, fibrillar collagens were reduced,
hereas fibronectin and tenascin were increased compared with those in normal
onditions. These matrix alterations were already evident in bicuspid nonaneurys-
al aortas at the convexity, with significant elevation of apoptotic indexes (P  .02
icuspid vs normal; P .48 tricuspid vs normal). Apoptotic indexes correlated with
ortic dimensions only in tricuspid aortas (P .01). No significant increase in Ki-67
as found. Higher levels of Bcl-2-modifying factor-Bcl-2 binding were found in
icuspid nonaneurysmal aorta versus tricuspid (P  .03) and normal aortas (P 
01). Bcl-2 messenger RNA expression was reduced in the bicuspid aorta versus
ormal (P  .08).
onclusions: Smooth muscle cell apoptosis with bicuspid aortic valve stenosis
ccurred before overt aortic dilation, mainly at the convexity, where wall stress is
xpectedly higher. In this setting, a matrix-dependent proapoptotic signaling was
videnced by increased Bcl-2-modifying factor-Bcl-2 binding. Stress-dependent
icuspid aortic valve matrix changes may trigger early apoptosis by inducing
ytoskeletal rearrangement.
he traditional definition of medial degeneration of the ascending aorta
includes the association of smooth muscle cell (SMC) loss, owing to apo-
ptosis,1,2 and extracellular matrix (ECM) rearrangement.3,4 Recently, re-
arkable improvements have been achieved in the knowledge of the mechanisms
nderlying ascending aortic dilations,1-4 but without identifying definite pathoge-
etic sequences. Indeed, medial degeneration can underlie a variety of anatomo-
linical conditions (eg, the senile aorta, poststenotic dilations, idiopathic or syn-
romic aneurysms, dissections), suggesting different possible mechanisms of lesion
scular Surgery ● January 2008
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A
CDevelopment.1 In particular, aortic dilations associated with
ongenital bicuspid aortic valve (BAV) are known to differ
rom those with tricuspid aortic valve (TAV) disease in
erms of histopathology,2 anatomic configuration,5 and nat-
ral history.6
In our preliminary investigation, we4 defined medial
CM changes in BAV-associated dilations, observing a
ecrease in collagen content versus normal aorta and an
ncrease in fibronectin and the expression of tenascin. How-
ver, no comparison with TAV-associated dilations and no
istinction between early changes and mature lesions were
erformed. The present study was undertaken as a more
n-depth continuation of the previous one,4 with the aim to
ssess spatial and temporal patterns of ECM protein and
MC changes in BAV- and TAV-associated aortic dila-
ions. Moreover, inasmuch as changes in the ECM compo-
ition, including those previously observed in BAV aortopa-
hy,3,4 are known to possibly influence SMC phenotype,
roliferation, survival, and synthetic activity,7,8 we focused
n the hypothesis that SMC apoptosis in ascending dilations
ould be provoked by matrix-derived signaling. Anoikis (the
ncient Greek word for homelessness) is the term indicating
poptosis caused by the loss of normal adhesion of cells to
normally organized ECM, occurring via altered cell
tensegrity,” the tensional integrity of the cytoskeleton.9
atrix disarray and/or cell detachment can induce loss of
ytoskeletal integrity, cell shape changes, and eventually
ell death9,10: thus, “amorphosis” is considered as a typical
eature/modality of anoikis.10,11 Proapoptotic cues are
nown to be transmitted to cells by the ECM in both the
ettings of vascular physiology and disease.9 In the present
tudy, we hypothesized that matrix-derived proapoptotic
ignals could be involved in the development of BAV
Abbreviations and Acronyms
AI  apoptotic index
BAV  bicuspid aortic valve
Bmf  Bcl-2-modifying factor
DAPI  4=,6-diamidino-2=-phenylindole
ECM  extracellular matrix
GAPDH glyceraldehyde-3-phosphate dehydrogenase
MMP matrix metalloproteinases
mRNA messenger RNA
PBS  phosphate-buffered saline
PCR  polymerase chain reaction
SMC  smooth muscle cell
TAV  tricuspid aortic valve
TUNEL  terminal deoxynucleotidyl transferase-
mediated dUTP nick end labelingortopathy. I
The Journal of Thoraatients and Methods
tudy Patients
he study included 26 patients with aortic valve stenosis (mean
ge 59  15 years, 65% male) undergoing aortic valve replace-
ent and/or ascending aorta replacement. Valve morphology
BAV/TAV) was defined on the basis of concordant echocar-
iographic diagnosis, surgical inspection, and pathologic exam-
nation. In case of discordances, patients were considered non-
ligible. Twelve patients had degenerative stenosis of a TAV,
nd 14 had a stenotic congenital BAV. Respective TAV and
AV subgroups were comparable for clinical and echocardio-
raphic data (Table E1). No patient had inherited connective
issue abnormalities, atherosclerotic aneurysm, or associated
ortic regurgitation (more than mild). To define temporal pat-
erns of medial change progression, we distinguished subgroups
ccording to aortic dimensions: nonaneurysmal aortas (mild
ilations) were defined as an aortic ratio (between echocardio-
raphically measured maximal diameter and expected diameter,
ased on age and body surface area) less than 1.4 (correspond-
ng, on average, to a diameter of 4.5 cm), and aneurysms were
efined as a ratio greater than 1.4.
ample Retrieval Protocol
t surgical inspection, all BAV-associated aortic aneurysms ap-
eared asymmetric, with predominant bulging of the right antero-
ateral side of the vessel. This configuration was found also in 3
AV aneurysms (60%), whereas the other 2 showed a fusiform,
ymmetric dilation at both the outer (convexity) and inner curves
concavity). The pattern of cusp fusion was right-left coronary in
2 BAV patients and right-noncoronary in the other 2. To define
patial patterns of lesion expression, according to a previously
ntroduced protocol,4 soon after the aortotomy was performed, we
etrieved 2 full-thickness aortic wall samples distal to the sinotu-
ular junction (maximal dilation level) in each patient: one at the
onvexity and the other at the concavity (from the two ends of the
ransverse aortotomy in patients without indication to concomitant
scending aorta replacement). Wall specimens were retrieved at
he same levels also from 3 normotensive heart donors during
ultiorgan procurement (2 men, 1 woman; mean age 40 3 years;
ean diameter 3.4  0.15 cm). Thus, 58 specimens overall were
vailable for examination. The study was approved by our insti-
ution’s ethical committee and patients gave informed consent.
mmunohistochemistry of Matrix Proteins
pecimens (n  52) were fixed in buffered 10% formalin, embed-
ed in paraffin, and sectioned. Serial 4 m-thick sections of aortic
pecimens were deparaffinized, covered with primary monoclonal
ntibodies against type I collagen, tenascin-C, and laminin or
olyclonal antibody for fibronectin (Sigma-Aldrich, St Louis, Mo),
nd type III collagen (Santa Cruz Biotechnology Inc., Santa Cruz,
alif), and incubated in a moist chamber for 1 hour at 37°C. After
ashings in phosphate-buffered saline (PBS), they were covered
ith fluoresceinated secondary antibodies (Sigma-Aldrich) and
eincubated. Nuclei were stained with propidium iodide, and then
ections were mounted in Vectashield mounting medium (Vector
aboratories, Burlingame, Calif) and observed with Leica DMLB
uorescence microscope (Leica Microsystems, Inc, Bannockburn,
ll). Moreover, a Zeiss LSM-510 confocal microscope (Karl Zeiss
cic and Cardiovascular Surgery ● Volume 135, Number 1 9
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A
CDnternational, Jena, Germany) was used to obtain full-thickness
econstructions of the aortic wall to describe spatial distribution of
roteins. To obviate the possible interference of elastin autofluo-
escence, however, quenched by pretreatment with toluidine blue
.1% solution, we also performed the immunoperoxidase method
or countercheck, using the standard avidin-biotin-peroxidase
omplex technique and the L.V. Dako LSAB kit (DAKO A/S,
arpinteria, Calif) after antigen retrieval by pressure cooking.
fter quenching in 3% hydrogen peroxide and blocking, the sec-
ions were incubated with primary antibodies for the aforemen-
ioned ECM proteins overnight at 4°C. Biotinylated secondary
ntibody and streptavidin conjugated to horseradish peroxidase
ere subsequently applied with color development with 3,3=-
iaminobenzidine and hematoxylin counterstaining. Negative con-
rol slides in the absence of primary antibody were included for
ach staining. Samples were evaluated with both methods by 3
ndependent observers blinded to the register that matched speci-
ens with patient clinical data, using a grading scale for semi-
uantification of staining, from none (0) to intense (4). Owing to
he overall good correspondence between fluorescence and perox-
dase assessments, each specimen was assigned 1 score (averaging
Figure 1. Immunostaining for laminin is shown as a
changes. A, Immunofluorescence method, confocal mis
 propidium iodide (nuclei). B, Immunoperoxidase me
methods indicated that in BAV patients laminin decrea
and more asymmetrical (ie, more severe at the convex
were from the inner portion of the media. ECM, Extra
aortic valve.he 6 scores from the 2 methods). t
0 The Journal of Thoracic and Cardiovascular Surgery ● Januassessment of SMC Density, Apoptosis, and
roliferation
all fragments from the concavity and convexity of the ascending
orta (n  54) were washed in PBS, fixed in 10% buffered
ormalin, paraffin-embedded, and sliced in 4-m serial sections.
fter deparaffinization, the ApopTag Plus Fluorescein In Situ
poptosis Detection Kit (Chemicon, Temecula, Calif) was used,
ccording to the manufacturer protocol. In brief, sections were
retreated with proteinase K for 15 minutes. Pre-equilibrated sec-
ions were covered with terminal deoxynucleotidyl transferase
orking solution and incubated for 1 hour at 37°C in a humidified
hamber. The reaction was stopped by incubation with stop/wash
uffer. After three washes with PBS, antidigoxigenin fluorescein
sothiocyanate conjugate (Sigma-Aldrich) was applied to the slides
or 30 minutes at room temperature. For characterization of apo-
totic cells, sections were subsequently incubated with anti-
mooth muscle -actin antibody (Sigma-Aldrich) for 1 hour at
7°C in a humidified chamber. After washes in PBS, rhodamine-
onjugated secondary immunoglobulin G antibody (Jackson Im-
unoResearch Laboratories, Inc, West Grove, Pa) was applied to
sentative example of the observed patterns of ECM
copy. Green fluorescence  laminin; red fluorescence
light microscopy, 200; laminin stained brown). Both
as earlier (ie, already evident in small-size dilations)
an at the concavity) than in TAV patients. All images
lar matrix; BAV, bicuspid aortic valve; TAV, tricuspidrepre
cros
thod,
se w
ity th
celluhe sections for 1 hour at 37°C. Cell nuclei were counterstained
ry 2008
A
CDFigure 2. Patterns of ECM changes by semiquantitative assessment of collagen type I, fibronectin, and tenascin
immunostainings. *P  .05 BAV versus TAV dilation; §P < .05 BAV versus normal (P  .016 for collagen type I; P
 .008 for fibronectin) and versus TAV dilation (P  .008 for collagen type I; P  .037 for fibronectin); °P < .05
aneurysm versus respective dilation (P  .007 for collagen type I in BAV; P  .03 and P  .01 for collagen type
I in TAV; P.002 for tenascin in BAV); P < .01 for all differences between convexity and concavity in BAV. P <
.05 (not significant) for all other comparisons. ECM, Extracellular matrix; TAV, tricuspid aortic valve; BAV, bicuspid
aortic valve.
The Journal of Thoracic and Cardiovascular Surgery ● Volume 135, Number 1 11
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1
A
CDith 4=,6-diamidino-2=-phenylindole (DAPI), and the sections
ere washed in PBS and mounted under a glass coverslip. The
lides were examined with a fluorescence microscope (Leica Mi-
rosystems) by 3 independent observers blinded to the register
atching specimens with patient clinical data: the number of
MCs in 1 mm2 (SMC density) and the rate of apoptotic SMCs
apoptotic index, AI) were determined counting 1000 nuclei in
ach section. For investigation of SMC proliferation, double im-
unostaining was performed (n  24) with the aforementioned
nti-actin antibody (Sigma-Aldrich) and primary rabbit polyclonal
ntibodies against the Ki-67 antigen (NovoCastra Laboratories
td, Newcastle upon Tyne, United Kingdom), previously un-
asked by pressure cooking in 10-mmol citric acid, pH 6. Ki-67 is
xpressed during late G1, S, G2, and M phases of the cell cycle,
ot in early G1 and G0.12
cl-2-modifying Factor-Bcl-2 Coimmunoprecipitation
nd Bcl-2 Messenger RNA Quantification
o assess the presence and degree of matrix-dependent cytoskel-
ton-mediated proapoptotic signals in aortic dilations, we quanti-
ed the interaction of Bcl-2-modifying factor (Bmf) with Bcl-2.
mf is a proapoptotic BH-3 only protein normally sequestered to
he myosin V actin motor complex13: when released by actin
ytoskeletal reorganization after altered matrix rigidity9-11,14 or
ell-matrix detachment,9,11 it binds to Bcl-2, initiating apoptosis.
he tissue fragments were fast frozen in liquid nitrogen and
ulverized. The samples (n  42) were suspended in a lysis buffer
ontaining 50 mmol/L Tris-HCl (pH 7.4), 5 mmol/L ethylenedia-
inetetraacetic acid, 250 mmol/L NaCl, 0.1% Triton X-100 sup-
lemented with proteases inhibitors (1 mmol/L dithiothreitol, 2
mol/L phenylmethylsulfonyl fluoride, 2 g/mL aprotinin, and 10
g/mL leupeptin), incubated on ice for 30 minutes to obtain total
ell lysate, and centrifuged at 14000g for 20 minutes. The protein
oncentration in the supernatant was determined with the BioRad
rotein Assay (Bio-Rad Laboratories, Hercules, Calif). The lysates
ontaining 300 g of proteins were incubated with anti-Bcl-2
ntibody (Santa Cruz Biotechnology) at4°C overnight, followed
y incubation with protein G agarose (Invitrogen Corporation,
arlsbad, Calif) for 3 hours. Immunoprecipitates were washed 3
imes and collected beads were boiled in Laemmli loading buffer
Bio-Rad Laboratories). The presence of Bmf bound to Bcl-2 was
nalyzed by electrophoresis on 12% sodium dodecylsulfate-polia-
rylamide gel and Western blot using anti-Bmf antibody (Santa
ruz Biotechnology).13 An incubation of tissue lysates with non-
pecific immunoglobulin G at the same concentration was used as
negative control for immunoprecipitation, and the absence of
ignal in control samples confirmed specificity. An internal control
ample was run on each gel for normalization. For corollary
ssessment of Bcl-2 expression, total RNA was isolated by lysis (n
20; 3 normal aortas and 7 BAV-associated mild dilations) in
RIzol solution (GIBCO BRL, Invitrogen Life Technologies,
ockville, Md). After the yield and integrity control of each RNA
ample, 2.5 to 5 g of total RNA was reverse-transcribed by using
he First-Strand cDNA Synthesis Kit (Amersham Pharmacia Bio-
ech, Arlington Heights, Ill) with the random hexamer primers.
he same volume (2 L) of products from each sample was used
or subsequent polymerase chain reaction (PCR) amplification
ith the primers reported in Appendix E1. Samples without com- m
2 The Journal of Thoracic and Cardiovascular Surgery ● Janualementary DNA served as negative controls for PCR amplifica-
ions. See Appendix E1 for the PCR program. The amplified
roducts were analyzed by electrophoresis in 2% agarose gel
ontaining ethidium bromide, and photographs were taken under
ltraviolet illumination. Bcl-2 messenger RNA (mRNA) expres-
ion was quantified by densitometry scanning and normalized
gainst glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
ontrols.
tatistical Analysis
aired t test (convexity vs concavity) and the Student t test (BAV
s TAV) were used for comparisons. One-way analysis of variance
ith Bonferroni post hoc correction was used for comparisons
etween normal, dilated, and aneurysmal aortas. Correlations were
nalyzed by computing the Pearson coefficient.
esults
CM Protein Expression
mmunohistochemistry with both fluorescence and peroxi-
ase methods allowed for semiquantitative definition of
hanges in the expression of ECM proteins and in their
ocalization within the medial layer. In aneurysmal aortas,
oth with BAV and TAV, media thickness was constantly
ecreased (1.17  0.2 mm) compared with normal (1.54 
.05 mm; P  .001). Collagen type I, collagen type III, and
aminin were reduced compared with normal, whereas fi-
ronectin was increased; tenascin was scarcely detected in
ormal aortas, whereas it was present in aneurysms. The
nner media (Figure 1) showed the most marked reduction
n laminin and collagen type I content, which gradually
ncreased toward the adventitia. In BAV aneurysms, all the
forementioned changes were more severe at the convexity
han at the concavity, whereas TAV aneurysms showed
ymmetrical changes (Figure 2). Also, in BAV small-size
ilations, the convexity showed reduction of collagens and
aminin and increase of fibronectin and tenascin (although
ess severe compared with aneurysms), whereas the concav-
ty showed near-normal amounts of proteins (Figure 2). In
AV mildly dilated aortas, ECM protein expression was
ore heterogeneous: normal mean amounts of proteins
ere observed in all TAV dilations, except for fibronectin
evels in 4 cases (slightly increased in 2, decreased in 2) and
ollagen I in 3 (increased). The lamellar structures evi-
enced in normal aorta appeared thinned, fragmented, and
isarrayed in patients, especially at BAV convexity.
MC Apoptosis Density and Proliferation
n the overall group of diseased aortas, the rates of terminal
eoxynucleotidyl transferase-mediated dUTP nick end la-
eling (TUNEL)-positive SMC nuclei were increased com-
ared with normal (P  .001). In TAV dilations, the AIs
ere remarkably heterogeneous, likely accounting for the
ack of statistically significant difference versus normal
ortas. In particular, of 14 available TAV dilation speci-
ens, 8 showed normal AIs and 6 had AIs even higher than
ry 2008
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A
CDFigure 3. SMC changes in TAV and BAV postste-
notic dilation. A, Comparison of SMC density
between subgroups. Smooth muscle cellularity
was generally higher in BAV than in TAV dila-
tions. The temporal pattern of SMC density
changes found in TAV was observed also at BAV
convexity. *P < .05 versus normal; §P < .05
versus respective dilation and P  not signifi-
cant versus normal; °P<.05 versus respective
concavity. B, Representative images illustrating
SMC density and apoptosis in the study sub-
groups (red fluorescence  -smooth muscle
actin positivity; blue fluorescence  DAPI stain-
ing for nuclei; cyan-green fluorescence TUNEL
positivity). C, Comparative graph of apoptotic in-
dexes (AI) in the subgroups. BAV aortas showed
a TAV-like pattern of AI increase with increasing
aortic dimensions only at the concavity. At the
convexity, the BAV aorta showed a significant
initial AI increase compared with normal, with-
out further significant increase in aneurysms
compared to dilations. *P < .05 versus normal
and versus respective dilation; §P < .05 versus
normal; °P < .05 versus respective concavity
(paired t test). SMC, Smooth muscle cell; TAV,
tricuspid aortic valve; BAV, bicuspid aortic valve;
SD, standard deviation.The Journal of Thoracic and Cardiovascular Surgery ● Volume 135, Number 1 13
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1
A
CDhose found in BAV dilations. In BAV dilations, AIs were
ignificantly higher than normal (P  .02) only at the
onvexity (Figure 3). In aneurysms, the AIs increased sig-
ificantly compared with small-size dilations at both con-
avity (P  .024) and convexity (P  .017) in TAV
atients, whereas in BAV aneurysms they increased only at
he concavity (P  .02) with significant difference versus
he convexity (P  .02). There was a significant correlation
etween aortic size and AI in TAV patients (concavity: r 
.69; P  .038; convexity: r  0.72; P  .030), but not in
AV patients (concavity: r 0.50; P .17; convexity: r
.03; P  .92). Normal aortas presented nonsignificantly
reater SMC density at the convexity (1543  69 cells/
m2) than at the concavity (1200  166 cells/mm2; P 
12). Small-size dilations showed decreased SMC density
ompared with normal aorta, whereas aneurysms showed an
ncrease compared with dilations, with near-normal values
P  .05 in aneurysm subgroups versus normal; Figure 3).
AV patients showed this 2-phase temporal pattern of SMC
ensity changes both at the concavity and at the convexity,
AV patients only at the convexity: in BAV concavity, a
teady trend in SMC density was observed (dilations versus
ormal: P .84; aneurysms versus dilations: P .77). Few
cattered smooth muscle actin-positive cells co-stained with
i-67 (0.06%  0.03%) in the media of normal aortas. In
neurysms (5 BAV, 4 TAV), the mean rate of medial
i-67-positive/-actin-positive cells was 0.07%  0.05%
P  .32 versus normal; Figure E1). Owing to limited tissue
vailability for experiments, no comparison between sub-
roups could be performed.
roapoptotic Versus Prosurvival Signaling
ow levels of Bmf-Bcl-2 binding were present in normal
ortas, showing that it may be a constitutive phenomenon;
owever, it was increased in patients, considered as one
roup, compared with normal (concavity: 0.92  0.17 vs
.72  0.01; P  .07; convexity: 1.10  0.24 vs 0.73 
.01; P  .02). Grouped together, all BAV patients pre-
ented higher levels of Bmf-Bcl-2 binding than the TAV
roup at the convexity (1.21  0.24 vs 0.96  0.16; P 
03; concavity: 0.93  0.19 vs 0.90  0.16; P  .83). As to
he temporal patterns of Bmf-Bcl-2 binding, it increased in
ild dilations compared with normal, but no further in-
rease was detectable in the aneurysm phase (Figure 4).
mf-Bcl-2 level did not correlate statistically with the AI.
he expression of Bcl-2 mRNA was lower in patients than
n normal subjects, although statistical significance was not
eached (optical density ratio to GAPDH: 0.2 0 0.09 vs
.29  0.2; P  .08).
iscussion
he main findings of this study may be summarized asollows: (1) BAV and TAV stenosis showed different tem- w
4 The Journal of Thoracic and Cardiovascular Surgery ● Januaoral patterns of ascending aorta medial remodeling, in that
AV was associated with significant SMC apoptosis even
efore overt enlargement of the vessel, whereas TAV was
haracterized by high variability in SMC apoptosis rates at
his early stage; (2) similarly, ECM remodeling was earlier
ith BAV, being characterized by collagen and laminin
eduction, fibronectin increase, and tenascin expression,
hereas only a proportion of TAV patients showed early
CM changes, in part discordant in nature with those seen
ith BAV; (3) BAV and TAV stenosis also showed differ-
nt spatial patterns of medial remodeling: asymmetric in
AV aortopathy, with the convexity more severely in-
olved than the concavity, and symmetric in TAV; (4)
lthough present also in normal aorta, Bmf-Bcl-2 binding
as significantly increased, in BAV small-size dilations, at
he convexity, with concomitant reduction of Bcl-2 expres-
ion, indicating a net proapoptotic alteration of cell-matrix
ignaling. These represented novel insights into the physio-
athology of ascending aorta dilations in the presence of
AV stenosis.
arly and Late SMC Changes
o our knowledge, only one previous report2 showed early
poptosis in the nonaneurysmal BAV aorta, although it
ncluded patients operated on for aortic stenosis, regurgita-
ion, coarctation, and coronary artery disease in one group.
owever, in studies assessing aortic wall changes, patient
amples should be homogeneous for valve function, inas-
uch as important differences have been found between
AV stenosis and regurgitation in terms of epidemiology5
nd morphologic/molecular features of ascending aortic di-
ation4: valve function can influence even the natural history
f dilation.6 Other investigations on SMC apoptosis in BAV
ortopathy analyzed only end-stage aneurysmal tissues.1,2
Our findings indicate that the cellular and extracellular
rocesses underlying aortic enlargement are already opera-
ive in the normally sized or slightly dilated BAV aorta
mean diameter 3.8 cm), although limited to the convexity.
he evidence of a “preclinical” aortopathy may add to the
urrent debates on whether and how to concomitantly ad-
ress the ascending aorta at the time of surgery for BAV
tenosis.15 The recent studies on matrix metalloproteinases3
MMPs), as well as gene mutational analyses,16 may poten-
ially pave the way for development of new diagnostic and
redictive strategies that may help to cope with this clinical
hallenge.
With increasing aortic dimensions (mean diameter 4.9 cm),
CM rearrangement at BAV convexity continued, whereas
MC density increased back to normal levels. A similar tem-
oral pattern was observed in the TAV setting, although ac-
ompanied by a significant increment of AIs, in apparent
ontrast with the increase in cellularity. Also, Tang and co-
orkers17 have recently found comparable SMC density in
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A
CDneurysms and nondilated aortas. Kirsch and colleagues18 ob-
erved higher SMC density in the maximal dilation area of
AV aneurysms than in the transition zone between normal
orta and maximal dilation, thus inferring a temporal pattern of
MC density changes concordant with our observations. How-
ver, neither one of those studies17,18 investigated SMC apo-
tosis and proliferation. Concomitant high AI and normal
MC density in our aneurysm specimens could not be ex-
lained by concurrent proliferation, since Ki-67 expression
as not increased compared with normal. Thus, we suggest
hat the loss of noncellular components of the media may have
uantitatively prevailed on SMC apoptotic loss, for faster pro-
ression of ECM breakdown, resulting in apparent normal
MC density, although the absolute cell number must have
ecreased. Although we could not calculate medial cross-
ectional areas,17 the aortic media was significantly thinned,
ven with mean diameters smaller than in previous studies.17,18
Figure 4. Top, Representative gels showing the result
bottom, comparison of Bmf-Bcl-2 binding levels betwee
Normalized optical density (arbitrary units); TAV, Tricu
deviation.n the other hand, a previous study showed medial cell pro- a
The Journal of Thoraciferation by Ki-67 staining in aortic dissection,19 a condition
hat may, however, be subtended by different remodeling pro-
esses compared with poststenotic dilations.1
The differences emerging in the patterns of lesional
aturation argue in favor of different mechanisms of early
edial remodeling in BAV versus TAV: in BAV aortopa-
hy, apoptosis may be part of the initiating events, whereas
n the TAV setting, at least in a proportion of patients, its
ccurrence is delayed, possibly representing a mechanism,
f not a consequence, of dilation itself.
eciprocal Influences Between ECM and SMC in
ortic Remodeling
he features of ECM remodeling observed in this study
eserve a comment in light of the known paradigms of
CM-SMC interplays.7,8 The increase in fibronectin with
oncomitant decrease in laminin suggests the constitution of
cl-2 immunoprecipitation with Western blot for Bmf;
groups (see text). *P<.05 versus normal. Relative O.D.,
aortic valve; BAV, bicuspid aortic valve; SD, standards of B
n sub
spidmicroenvironment that favors SMC phenotype modulation
ic and Cardiovascular Surgery ● Volume 135, Number 1 15
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CDrom the contractile to the synthetic phenotype.8 This sug-
estion is confirmed by the evidence that the glycoprotein
enascin-C, scarcely detectable in normal aortas, but typi-
ally produced by SMCs in synthetic phenotype,4,20 was
xpressed in aneurysms and also in the greater curvature of
AV-related mild dilations. Furthermore, other markers of
ynthetic phenotype have been found in medial degenera-
ion of the ascending aorta.1 The more significant reduction
n collagens and laminin in BAV versus TAV dilations is
onsistent with the greater increase in MMP-2 observed in
AV by Ikonomidis and coworkers.3 In our previous
tudy,4 collagenolysis in BAV stenotic aorta was suggested
y decreased collagen type I, as assessed by Western blot,
espite normal expression of collagen type I mRNA. In-
eed, tenascin and MMPs are tightly connected in vascular
emodeling: tenascin is capable to activate MMPs and, in
urn, proteolysed collagen type I stimulates tenascin
roduction.20
In the present study, we sought to assess whether ECM
hanges in BAV aortopathy could exert a causative influ-
nce also on SMC apoptosis. Although promoting SMC
urvival and proliferation is the physiologic function attrib-
ted to tenascin in vessel development and response to
njury,20 it has been shown that in conditions of MMP
verexpression, enzymatic degradation of tenascin leads to
he exposition of domains in its molecule that are proapop-
otic for SMCs.21 Similarly, fibronectin is a survival factor
or SMCs,7,8 although its proteolysis by plasmin and MMPs
roduces prodetachment/proapoptotic fragments.9 There-
ore, the MMP repertoire typically expressed in the BAV
orta3 may convert a prosurvival ECM into a proapoptotic
nvironment for SMCs. Notably, extrinsic proapoptotic
ues are known to be transmitted within the cells through
tructural rearrangements of the actin cytoskeleton, so that
hanges in cell-matrix interactions are accompanied by cell
hape changes (gross cell rounding, but also subtler disor-
ers) as part of the causative mechanism of apoptosis
“amorphosis”).11,22,23 To be able to interact with Bcl-2 and
o promote apoptosis, Bmf must be released by its normal
ite, where it is thought to serve as a sensor of actin
ytoskeleton integrity.13,14 Our finding of a significant in-
rease in Bmf-Bcl-2 interaction in BAV convexity at an
arly stage of dilation development strongly suggests that
earrangements in SMC cytoarchitecture may be brought
bout by early ECM changes and, in turn, convey a pro-
poptotic signal. ECM-dependent apoptosis does not nec-
ssarily require cell detachment (anoikis proper): alterations
f matrix geometrical organization or physical properties
an trigger this mechanism of programmed cell death even
ithout detachment.9-11,13 Indeed, we observed a reduction
f Bcl-2 mRNA, whose expression is regulated also by
atrix-dependent cytoskeletal changes.22,23 The fact that
mf-Bcl-2 did not further increase in larger aneurysms, w
6 The Journal of Thoracic and Cardiovascular Surgery ● Januaespite the increment in AI, suggests that late apoptosis,
oth in TAV aneurysms and in BAV concavity, may result
rom other pathways. Our study did not explore, for exam-
le, the apoptotic pathway of cytokine signaling, and the
ossible involvement of inflammatory mediators17,18 should
e investigated in early versus late lesions. However, late
poptosis may be not a causative factor but rather a conse-
uence of aneurysm growth itself, and another possible
ause could be increased wall strain owing to enlargement
nd loss of elasticity.17 Apoptosis in response to cyclic
train has been shown to occur in well-differentiated con-
ractile SMCs, but not in those that have undergone pheno-
ype change24: consistently, we found no AI elevation in
AV aneurysm convexity, where a greater expression of
CM proteins promoting phenotype switch was observed.
Pathogenetic Hypothesis
he asymmetrical spatial pattern of ECM and SMC changes
niquely found in early BAV dilations introduces, in the
ong-standing debate on the pathogenesis of BAV-related
ortic disease, evidence in favor of a determinant or at least
ontributory role of hemodynamics. A BAV stenosis, being
symmetric in geometry, produces an eccentric jet yielding
ore severe flow alterations in the ascending aorta than
AV stenosis with similar gradients and valve areas.25
AV-related turbulences have been shown to produce un-
ven wall stress distribution, with overload at the aortic
ight anterolateral wall (convexity).26 Conversely, a hypo-
hetical inborn wall defect2 sufficient to cause dilation
hould produce a remodeling process uniformly involving
he whole aortic circumference, which was denied by the
resent study. Thus, we hypothesize that altered flow (even
hough not necessarily a “clinically” altered flow25,26) could
e either the triggering cause of early wall lesions or the
actor required for local expression of a latent defect. Both
n vitro and in vivo studies have shown SMC phenotype
hange,27 fibronectin and tenascin production,27 and in-
reased MMP expression and activity28 to be elicited by
ndue biomechanical stress, as well as apoptotic SMC
eath, with reduced Bcl-2 expression,24 as found in the
resent study, and increased p53 expression,29 as found by
hling and colleagues19 in medial degeneration. In our hy-
othesis, stress-induced early ECM changes unique to BAV
onvexity promote early SMC apoptosis, at least in part
hrough Bmf-Bcl-2 interaction, leading to progressive, typ-
cally asymmetric aortic enlargement.
However, further work is needed to verify this theory.
he possibility cannot be discarded that BAV might be
ssociated with a congenital anomaly of some component of
atrix signaling pathways, and flow disturbances at the
onvexity could merely accelerate locally the degenerative
rocess, however destined to involve also the concavity
ithin a longer time span.
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A
CDtudy Limitations
first limitation of the present study concerns the ref-
rence control group (“normal aorta”): the most appro-
riate control subjects for comparison with patients with
AV aortopathy should have been the nonstenotic BAV
ith normal-sized aorta, a setting that was not repre-
ented in our surgical specimens. Second, the reason for
he choice of Bmf-Bcl-2 measurement as the sign of
roapoptotic cytoskeleton rearrangement was that Bmf
elease does not occur in response to other types of
poptotic stimuli in vivo.10,13 Cell-matrix detachment has
ever been demonstrated in medial degeneration; thus,
ur starting hypothesis was that altered matrix solidity
ould be rather responsible for proapoptotic signal-
ng.11,13 However, whether cell anchorage is lost or not
emains to be discerned, and to this scope, caspase 8 and
ntegrins may represent interesting targets: caspase 8
ctivity increases after loss of integrin-mediated anchor-
ge, but Bmf can be released without caspase 8 activation
n the case of cytoskeleton rearrangement without detach-
ent.14,22 Finally, smooth muscle -actin and other SMC
arkers can be expressed also by myofibroblasts, migrat-
ng from the adventitial layer to the media during vascu-
ar remodeling, for example, in response to mechanical
njury.30 Thus, our study, as well as the previous ones
sing smooth muscle actin staining,1,2,17-19 could not
ifferentiate myofibroblasts from SMCs in the media, and
he assessment of the role of resident cell types other than
MCs awaits further study.
onclusions
patiotemporal patterns of ECM and SMC changes in the
ilating ascending aorta were found to differ between BAV
nd TAV stenosis, because matrix disruption and SMC
poptosis were earlier alterations in BAV than those in
AV, preceding overt enlargement of the vessel and pecu-
iarly located in the aortic wall area of the greater curvature,
r convexity. TAV-related dilation constitutes a more het-
rogeneous phenomenon, likely resulting from a variety of
ausative mechanisms. The processes of cell-matrix signal-
ng represent a potential field of investigation for future
esearch aiming to elucidate the etiology of BAV-related
scending aorta dilation.
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iscussion
ohn S. Ikonomidis (Charleston, SC). I congratulate Dr Della
orte for an outstanding study, which showed temporospatial
hanges in extracellular proteins, vascular smooth muscle density,
nd indexes of apoptosis in normal or aneurysmal ascending aortic
pecimens taken from patients with normal or stenotic BAVs or
AVs.
In particular, and in keeping with previous studies from this
roup, extracellular matrix protein changes were particularly im-
ortant in the convexity of aneurysmal ascending aorta associated
ith BAVs. In addition, evidence of early SMC apoptosis was
emonstrated. Of particular relevance here is evidence presented
hat anoikis, or apoptosis, which is induced by the loss of integrin-
ediated cellular attachments, participates in the process of SMC
ttrition as the aneurysm develops. This, of course, makes sense
ecause extracellular matrix remodeling and its attendant changes
f cellular matrix interactions are universal features of aortic
neurysm development.
I have 4 questions: Your extracellular protein assessments were
onducted by immunohistochemical techniques. Elastin was not
ncluded in these results but is known to cause significant autofluo-
escence in these studies. How did you correct for this phenome-
on when you were assessing the other proteins?
Dr Della Corte. Thank you, Dr Ikonomidis. My coworkers
rom the biomorphology department used to pre-tract tissues with o
8 The Journal of Thoracic and Cardiovascular Surgery ● Januaoluidine blue solution and then they used a very selective green
lter for fluorescence microscopy to obviate elastin autofluores-
ence.
We have already published our preliminary results with ECM
rotein assessment using both immunohistochemistry and Western
lot, which is not affected by elastin autofluorescence, and the
esults of the two methods were highly consistent.
Dr Ikonomidis. Second question: Your data suggest that SMC
poptosis is primed and occurs early in the course of aneurysm
evelopment. However, in the later phase of aneurysm develop-
ent, you demonstrate an increase in SMC density. How do you
xplain these findings and did you examine fibroblast profiles as a
econd resident cell within the aortic aneurysm wall?
Dr Della Corte. We didn’t look at other resident cell types in
his study, and this may be an interesting point for future research.
owever, both the evidence of smooth muscle cell loss in an early
hase of dilation with bicuspid valves and that of an increase in
mooth muscle cell density in aneurysms compared to small dila-
ions (resulting in near-normal cell density) have been already
eported in two different studies by other authors. Here we have
ried to suggest a common interpretation for those two findings in
he light of cell-matrix interactions. Cell-matrix signaling may be
esponsible for early apoptosis with the anoikis mechanism, as we
ave demonstrated it, but also, in the later phase of aneurysm
evelopment, the effect of increased morphogenetic pro-survival
roteins, like fibronectin and tenascin, may explain smooth muscle
ell density increase.
Dr Ikonomidis. Were you able to stratify these data relative to
he degree of aortic stenosis?
Dr Della Corte. We tried to compare subgroups of patients
ith different degrees of valve stenosis, but no difference in aortic
all changes emerged. However, we expected such results, be-
ause other factors may be important besides the degree of aortic
alve stenosis, as for example the time duration of valve disease.
Dr Ikonomidis. Last, have you related any of your changes to
rofiles of known protease systems such as MMPs?
Dr Della Corte. We observed a greater decrease in collagen in
AV compared with TAV patients, and this may be consistent
ith the increase in MMP-2 expression that is quite unique to the
AV setting, or at least greater in BAV than in TAV patients.
Similarly, our finding of increased tenascin and fibronectin
xpression may be consistent with the decrease in MMP-3 that
our group has demonstrated in the setting of bicuspid aortopathy.
owever, we should keep in mind that protein amount is the result
f a fine balance between production and degradation of proteins.
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CDppendix E1
olymerase chain reactions (PCRs) were performed with the fol-
owing program:
1. Initial denaturation for 5 minutes at 95°C
2. Denaturation for 45 seconds at 95°C
3. Annealing for 1 minute at 59°C
4. Extension for 2 minutes at 68°C
5. Final extension at 68°C for 5 minutes
The following primers of the Bcl-2 gene and the glyceralde-
yde-3-phosphate dehydrogenase (GAPDH) housekeeping gene
ere used for PCR (expected size of the amplification product):
The Journal of Thoracic● Bcl-2: 5=-ATGCCAAGGGGGAAACACCAG-3= (forward
primer)
● 5=-AGACAGCCAGGAGAAATCAAA-3’ (reverse primer)
(831 bp)
● GAPDH: 5=-CACCATCTTCCAGGAGCGAG-3= (forward
primer)
● 5=-TCACGCCACAGTTTCCCGGA-3= (reverse primer)
(372 bp)and Cardiovascular Surgery ● Volume 135, Number 1 18.e1
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CDABLE E1. Within groups of aortic dimensions (small-s
omogeneous in terms of age, prevalence of hypertension
TAV/dilation (n  7) BAV/dilatio
ge (y) 60 9 54
ypertension (rate) 57% 43
aximum gradient (mm Hg) 114 44 95 
ean gradient (mm Hg) 76 32 63
OAI (cm2/m2) 0.31 0.02 0.35
ild aortic regurgitation (rate) 29% 43
scending aorta (cm) 3.8 0.5 3.8
inotubular ridge (cm) 3.4 0.5 3.5
inuses (cm) 3.2 0.4 3.5
ortic ratio 1.19 0.15 1.15
AV, Tricuspid aortic valve; BAV, bicuspid aortic valve; EOAI, effective
AV/aneurysm. Additionally, no significant difference (P  .05) was foun
neurysms in terms of age and stenosis severity.
Figure E1. Representative images of Ki-67 staining (a
between a normal aorta, a BAV aneurysm, and a TAV aize dilations and aneurysms), BAV and TAV patients were
, aortic valve stenosis parameters, and aortic dimensions
n (n  7) P* TAV/aneurysm (n  5) BAV/aneurysm (n  7) P†
14 .37 67 11 60 15 .47
% .50 60% 57% .69
16 .43 62 8 79 16 .13
12 .47 40 5 47 9 .11
0.1 .58 0.42  0.03 0.37 0.07 .39
% .50 60% 57% .69
0.6 .98 5.0  0.3 4.9 0.4 .82
0.4 .68 4.3  1.1 3.7 0.7 .38
0.4 .21 3.9  0.6 3.8 0.7 .91
0.17 .68 1.54 0.14 1.55 0.12 .92
orifice area index. *TAV/dilation versus BAV/dilation; †TAV/aneurysm versus
d when comparing BAV dilations versus aneurysms and TAV dilations versusrrows) showing no difference in SMC proliferative index
neurysm. TAV, Tricuspid aortic valve; BAV, bicuspid aorticvalve.
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